Eritrea vs Japan: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Eritrea
96.0%
in 2025
Japan
96.0%
in 2025
Eritrea rank
27th
Japan rank
27th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Eritrea
- Japan
How they compare
Eritrea currently reports 96.0% against 96.0% in Japan, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Japan ahead.
Eritrea ranks 27th and Japan ranks 27th of 194 countries.
Japan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Eritrea | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 38.0% | 88.1% | 50.1% | Japan |
| 2020s | 95.2% | 95.3% | 0.2% | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Eritrea or Japan?
- Eritrea, at 96.0% against 96.0% in Japan as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Eritrea and Japan?
- 0.0%, with Eritrea ahead.
- How many years of comparable data are there for Eritrea and Japan?
- 18 years are reported by both, from 2008 to 2025.
- How do Eritrea and Japan rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Eritrea ranks 27th and Japan ranks 27th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.